These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21989490)

  • 21. Isolating potentiated Hsp104 variants using yeast proteinopathy models.
    Jackrel ME; Tariq A; Yee K; Weitzman R; Shorter J
    J Vis Exp; 2014 Nov; (93):e52089. PubMed ID: 25407485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prokaryotic chaperones support yeast prions and thermotolerance and define disaggregation machinery interactions.
    Reidy M; Miot M; Masison DC
    Genetics; 2012 Sep; 192(1):185-93. PubMed ID: 22732191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATP modulates self-perpetuating conformational conversion generating structurally distinct yeast prion amyloids that limit autocatalytic amplification.
    Mahapatra S; Sarbahi A; Punia N; Joshi A; Avni A; Walimbe A; Mukhopadhyay S
    J Biol Chem; 2023 May; 299(5):104654. PubMed ID: 36990219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substrate Discrimination by ClpB and Hsp104.
    Johnston DM; Miot M; Hoskins JR; Wickner S; Doyle SM
    Front Mol Biosci; 2017; 4():36. PubMed ID: 28611991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Hsp104 N-terminal domain enables disaggregase plasticity and potentiation.
    Sweeny EA; Jackrel ME; Go MS; Sochor MA; Razzo BM; DeSantis ME; Gupta K; Shorter J
    Mol Cell; 2015 Mar; 57(5):836-849. PubMed ID: 25620563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic Insights into Hsp104 Potentiation.
    Torrente MP; Chuang E; Noll MM; Jackrel ME; Go MS; Shorter J
    J Biol Chem; 2016 Mar; 291(10):5101-15. PubMed ID: 26747608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities.
    Shorter J; Lindquist S
    Mol Cell; 2006 Aug; 23(3):425-38. PubMed ID: 16885031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial and Yeast AAA+ Disaggregases ClpB and Hsp104 Operate through Conserved Mechanism Involving Cooperation with Hsp70.
    Kummer E; Szlachcic A; Franke KB; Ungelenk S; Bukau B; Mogk A
    J Mol Biol; 2016 Oct; 428(21):4378-4391. PubMed ID: 27616763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hsp104: a weapon to combat diverse neurodegenerative disorders.
    Shorter J
    Neurosignals; 2008; 16(1):63-74. PubMed ID: 18097161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Species-specific collaboration of heat shock proteins (Hsp) 70 and 100 in thermotolerance and protein disaggregation.
    Miot M; Reidy M; Doyle SM; Hoskins JR; Johnston DM; Genest O; Vitery MC; Masison DC; Wickner S
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6915-20. PubMed ID: 21474779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hsp70 targets Hsp100 chaperones to substrates for protein disaggregation and prion fragmentation.
    Winkler J; Tyedmers J; Bukau B; Mogk A
    J Cell Biol; 2012 Aug; 198(3):387-404. PubMed ID: 22869599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insight into molecular basis of curing of [PSI+] prion by overexpression of 104-kDa heat shock protein (Hsp104).
    Helsen CW; Glover JR
    J Biol Chem; 2012 Jan; 287(1):542-556. PubMed ID: 22081611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans.
    Duennwald ML; Echeverria A; Shorter J
    PLoS Biol; 2012; 10(6):e1001346. PubMed ID: 22723742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chaperone networks in protein disaggregation and prion propagation.
    Winkler J; Tyedmers J; Bukau B; Mogk A
    J Struct Biol; 2012 Aug; 179(2):152-60. PubMed ID: 22580344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional analysis of proposed substrate-binding residues of Hsp104.
    Howard MK; Sohn BS; von Borcke J; Xu A; Jackrel ME
    PLoS One; 2020; 15(3):e0230198. PubMed ID: 32155221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of Hsp104/ClpB inhibition by prion curing Guanidinium hydrochloride.
    Kummer E; Oguchi Y; Seyffer F; Bukau B; Mogk A
    FEBS Lett; 2013 Mar; 587(6):810-7. PubMed ID: 23416293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and mechanistic insights into Hsp104 function revealed by synchrotron X-ray footprinting.
    Sweeny EA; Tariq A; Gurpinar E; Go MS; Sochor MA; Kan ZY; Mayne L; Englander SW; Shorter J
    J Biol Chem; 2020 Feb; 295(6):1517-1538. PubMed ID: 31882541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymmetric deceleration of ClpB or Hsp104 ATPase activity unleashes protein-remodeling activity.
    Doyle SM; Shorter J; Zolkiewski M; Hoskins JR; Lindquist S; Wickner S
    Nat Struct Mol Biol; 2007 Feb; 14(2):114-22. PubMed ID: 17259993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new perspective on Hsp104-mediated propagation and curing of the yeast prion [PSI (+) ].
    Helsen CW; Glover JR
    Prion; 2012 Jul; 6(3):234-9. PubMed ID: 22561166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory circuits of the AAA+ disaggregase Hsp104.
    Franzmann TM; Czekalla A; Walter SG
    J Biol Chem; 2011 May; 286(20):17992-8001. PubMed ID: 21454552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.